PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-11-02

Date Title Company
02-Nov-2022 24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference Businesswire
02-Nov-2022 Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products Businesswire
02-Nov-2022 Applied Industrial Technologies Acquires Automation, Inc. Businesswire
02-Nov-2022 OrsoBio Acquires Phase 2-Ready, Selective ACC2 Inhibitor from Shionogi & Co., Ltd. for the Treatment of Type 2 Diabetes Businesswire
02-Nov-2022 Blaze Bioscience Announces Enrollment is Complete on its Pivotal Phase 2/3 Trial of tozuleristide and the CanvasTM Imaging System in Pediatric Central Nervous System Tumors Businesswire
02-Nov-2022 Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline Businesswire
02-Nov-2022 Kenco Group Launches Life Sciences Division Businesswire
02-Nov-2022 Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform Businesswire
02-Nov-2022 Amneal Receives FDA Approval for Leuprolide Acetate Injection Businesswire
02-Nov-2022 Equillium Announces Initiation of Phase 1 study of EQ102, A First-in-Class Multi-Cytokine Inhibitor of IL-15 and IL-21 Targeting Celiac Disease Businesswire
02-Nov-2022 Stratasys Makes Strategic Investment in Axial3D Businesswire
02-Nov-2022 Bluestar Genomics Presents Positive Results From Validation Study in Pancreatic Cancer Detection at American Pancreatic Association (APA) Annual Meeting Businesswire
02-Nov-2022 Can-Fite: Positive New Data from it’s Phase III Psoriasis Study will be Presented Today at an Industry Expert Summit in Boston Businesswire
02-Nov-2022 2022 China Crop Protection China Monthly Report: Stay Ahead in the Fast-Changing Market With Real-Time Reporting on the Whole Industrial Chain - ResearchAndMarkets.com Businesswire
02-Nov-2022 BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma Businesswire
02-Nov-2022 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Nov-2022 Sense and Biotecom Agree to Distribute Rapid, Instrument-Free Molecular Test, Veros COVID-19 in Chile Businesswire
02-Nov-2022 Charles River Laboratories Announces Third-Quarter 2022 Results Businesswire
02-Nov-2022 Redwire Launching Upgraded 3D Bioprinter to Space Station to Investigate New Treatment to Aid Military Service Members, Expands Crop Production Research and Materials Testing on Orbit Businesswire
02-Nov-2022 Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022 Businesswire